海洋抗癌药物在调节miRNA和抗氧化剂信号传递中的作用
Ya-Ting Chuang1, Ching-Yu Yen2, Jen-Yang Tang3
1Department of Biomedical Science and Environmental Biology, PhD Program in Life Sciences, College of Life Science, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Chemico-biological interactions
|July 17, 2024
概括
海药通过通过miRNA调节诱导氧化应激来对抗癌症. 本综述绘制了海洋药物,它们的miRNA和抗氧化剂点的地图,有助于抗癌药物发现和保护非癌细胞.
科学领域:
- 海洋药理学和癌症治疗学.
- 分子生物学,专注于微RNAs (miRNAs) 和氧化应激.
- 生物信息学和药物目标识别.
背景情况:
- 海洋衍生化合物因其抗癌性质而闻名,通常通过诱导癌细胞的氧化应激来调解.
- 反氧化稳态的平衡至关重要;不平衡的状态,特别是低调的抗氧化信号传递,促进氧化应激和癌细胞死亡.
- 众所周知,海洋药物可调节miRNA表达,但它们在向抗氧化途径方面的具体作用仍未得到充分探索.
研究的目的:
- 系统地审查和分类调节miRNAs以降低抗氧化剂标的海洋药物,从而诱导抗癌氧化应激.
- 为了识别由海洋药物下调的miRNAs,以在非癌细胞中提供抗氧化剂保护.
- 为潜在的治疗应用界定连接海洋药物的网络,它们的调节miRNA和它们的抗氧化剂点.
主要方法:
- 文献综述侧重于海洋药物,miRNAs和癌症中的氧化应激.
- 根据它们对抗氧化剂点的影响对海洋药物调节的miRNA进行分类 (抗癌降调,保护上调).
- 利用生物信息学工具miRDB预测和总结miRNA调节海洋药物的假定抗氧化标.
主要成果:
- 识别和分类影响miRNA表达的海洋药物,以调节抗氧化途径.
- 编制了一份由海洋药物介导的miRNA调节影响的潜在抗氧化剂标清单.
- 建立了一个框架,以了解海洋药物,miRNA和抗氧化机制之间的复杂关系.
结论:
- 海洋药物通过操纵miRNA控制的抗氧化剂信号通路,为抗癌疗法提供了一个有希望的途径.
- 鉴定的网络为探索新型海洋衍生抗癌剂和理解它们的细胞保护作用提供了精确的基础.
- 对这些特定药物-miRNA-目标相互作用的进一步研究可以加速针对性海洋癌症治疗的开发.
相关概念视频
Electron Transport Chain: Complex I and II
12.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


